Registered Nurse: CAR-T Stem Cell Transplant Specialist

Jobot; Phoenix (AZ); Sur place; USD 80 000 - 120 000; Plein temps

Avantages offerts par ce poste

$25K Sign-on Bonus

Comprehensive benefits package

Retirement benefits - 401(k) with company match

Tuition Reimbursement

Paid Time Off (PTO) starting on day 1

Résumé du poste

Jobot is seeking a Registered Nurse - Stem Cell Transplant in Phoenix, Arizona. This position offers a competitive salary of $80,000 - $120,000 annually along with a $25K sign-on bonus. Join a top healthcare organization that values career growth and provides comprehensive benefits including health, dental, vision insurance, and a retirement plan with a company match. Candidates should have a BSN degree and relevant nursing certifications, with experience in oncology and stem cell transplants preferred.

Qualifications

• Experience with CAR-T, Oncology, Hematology, Cellular Therapies, Transplants, Stem Cell, Bone Marrow Transplant (BMT) or related specialty area required.
• Must be a Registered Nurse with an active AZ RN License or eligible.
• ACLS and BLS Certifications are mandatory.

Responsabilités

• Join an engaged leadership team focused on patient care.
• Provide nursing care for stem cell transplant patients.
• Monitor patient progress and collaborate with multidisciplinary teams.

Connaissances

Experience with CAR-T

Oncology

Hematology

Cellular Therapies

Transplants

Bone Marrow Transplant (BMT)

ACLS Certification

BLS Certification

Oncology Nurse Certified (OCN)

Formation

BSN Degree

Description du poste

Jobot is seeking a Registered Nurse - Stem Cell Transplant in Phoenix, Arizona. This position offers a competitive salary of $80,000 - $120,000 annually along with a $25K sign-on bonus. Join a top healthcare organization that values career growth and provides comprehensive benefits including health, dental, vision insurance, and a retirement plan with a company match. Candidates should have a BSN degree and relevant nursing certifications, with experience in oncology and stem cell transplants preferred.